To evaluate the effects of the drug on different levels of neuronal activity involved in sympathetic nerve outputs, we performed experiments using the following three types of in vitro preparations: 1) Sympathetic nerve retained preparation: SNA was recorded in preparations with the thoracic sympathetic nerve trunk, as previously described [17]
GLP-1-class drugs amplify this in one indirect way: they work largely by suppressing appetite, which can drive protein intake and overall calories very low if a person simply "isn't hungry." Under-eating protein while losing weight quickly is the single biggest driver of avoidable muscle loss
I thought of Clunes essay often as I followed last years media coverage of Ozempic, Wegovy, Mounjaro, and other new medications that cause weight loss (from here, Ill just use Ozempic as a shorthand for the whole class)
If left untreated, it can lead to coma and even death
This information, interpreted with a qualified healthcare provider, can support discussion of whether a cautious microdose approach suits your genetic predispositions
Xie P, Abildlund MT, Baekdal TA, et al